Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Completed
A Phase 1/2 Study to Evaluate Axatilimab in Participants With Active cGVHD
NCT03604692· Phase 1/2· Syndax Pharmaceuticals· Source
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error